Abstract:Highlights • Colorectal cancer (CRC), which is mainly caused by epigenetic and lifestyle factors, is very often associated with functional plasticity during its development. • Tumor cell plasticity (epithelial-mesenchymal transition as well as cancer cell stem cells) leads to metabolic reprogramming of cancer cells and promotes tumorigenic potential, drug resistance and metastasis, which is of great therapeutic importance. • The tumor protein p53 acts as one of the central suppressors of carcinogenesis by regulating its target genes, whose proteins are involved in the plasticity of cancer cells, autophagy, the cell cycle, apoptosis and DNA repair. • The specific modulation of such proteins by natural compounds as prophylaxis or specific intervention therefore represents a therapeutic approach. • There is a link between anti-functional plasticity (EMT, CSC, metabolism), pro-apoptosis and modulation of the p53 signaling pathway in CRC cell oncogenesis as one of the main resveratrol mechanisms to suppress or reverse the malignant phenotype, cell migration ability and resistance to conventional drugs in vitro and in vivo , suggesting a great therapeutic importance. Background Colorectal cancer (CRC), which is mainly caused by epigenetic and lifestyle factors, is very often associated with functional plasticity during its development. In addition, the malignant plasticity of CRC cells underscores one of their survival abilities to functionally adapt to specific stresses, including inflammation, that occur during carcinogenesis. This leads to the generation of various subsets of cancer cells with phenotypic diversity and promotes epithelial-mesenchymal transition (EMT), formation of cancer cell stem cell (CSC) and metabolic reprogramming. This can enhance cancer cell differentiation and facilitate tumorigenic potential, drug resistance and metastasis. Aim of Review The tumor protein p53 acts as one of the central suppressors of carcinogenesis by regulating its target genes, whose proteins are involved in the plasticity of cancer cells, autophagy, cell cycle, apoptosis, DNA repair. The aim of this review is to summarize the latest published research on resveratrol's effect in the prevention of CRC, its regulatory actions, specifically on the p53 pathway, and its treatment options. Key Scientific Concepts of Review Resveratrol, a naturally occurring polyphenol, is a potent inducer of a variety of tumor-controlling. However, the underlying mechanisms linking the p53 signaling pathway to the functional anti-plasticity effect of resveratrol in CRC are still poorly understood. Therefore, this review discusses novel relationships between anti-cellular plasticity/heterogeneity, pro-apoptosis and modulation of tumor protein p53 signaling in CRC oncogenesis, as one of the crucial mechanisms by which resveratrol prevents malignant phenotypic changes leading to cell migration and drug resistance, thus improving the ongoing treatment of CRC. Graphical abstract Download : Download high-res image (148KB) Download : Download full-size image

Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment

Interplay Between Apoptosis and Autophagy in Colorectal Cancer

Resveratrol and p53: How are they involved in CRC plasticity and apoptosis?

Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment

Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions

P53/microrna-374B/akt1 Regulates Colorectal Cancer Cell Apoptosis in Response to DNA Damage.

Resveratrol Induces Apoptosis of Pancreatic Cancers Cells by Inhibiting Mir-21 Regulation of BCL-2 Expression

Tanshinone I Induces Human Colorectal Cancer Cell Apoptosis: the Potential Roles of Aurora A-p53 and Survivin-Mediated Signaling Pathways.

Resveratrol triggers autophagy‐related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1

Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells.

Resveratrol Inhibits Colorectal Cancer Cell Tumor Property by Activating the miR-769-5p/MSI1 Pathway

Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells

Resveratrol Induces Apoptosis in Pancreatic Cancer Cells

Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21

SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53/miR-101/KPNA3 axis.

Involvement of c-jun NH2-terminal kinases in resveratrol-induced activation of p53 and apoptosis

Resveratrol Induces Cancer Cell Apoptosis Through MiR-326/PKM2-Mediated ER Stress and Mitochondrial Fission.

Resveratrol Regulates Hsp60 in HEK 293T Cells During Activation of SIRT1 Revealed by Nascent Protein Labeling Strategy

Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells

Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Mice Through SIRT1-mediated Deacetylation of P53